ArticleFrontiers in immunology2025

C-reactive protein flare: a promising prognostic predictor for patients with hepatocellular carcinoma treated with TACE combined with lenvatinib and immune checkpoint inhibitors.

Xinge Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.